Abstract 442P
Background
The number of permanent colostomies performed for rectal cancer is decreasing as trans-anal excision has become the first-choice surgical approach. However, the types of support required for patients who undergo permanent colostomies according to their courses are not elucidated. This study aims to identify the types of support needed by elderly permanent colostomy patients by the postoperative months and investigated how these affected their quality of life.
Methods
This study was performed by a hypothesis testing approach using an anonymous self-administered questionnaire, which were left with the participants, and 335 members of A Ostomy Association were recruited to participate. The questionnaire had three components: 11 original items about care needed by individuals with colostomies, the Ostomate QOL Survey and the SF-12v2. Basic respondent characteristics were totaled by simple tabulation, and correlation and multiple regression analyses were performed to investigate how the number of postoperative months affected the support that the individuals with permanent colostomies wished for, and how the support they wished for affected QOL. The survey period was September 2017. This study was approved by the research ethics committee of the institution.
Results
Data from 137 participants of the mean age of 76.5 years were included in the analysis. The analysis on how support individuals felt needed with permanent colostomies affected their QOL resulted in significant correlations between “Factors related to daily life” , “Physical condition” (β=-.294, p=.011), “Activity” (β=-.267, p=.011) and “Mental and emotional condition” (β=-.410, p=.000). The multiple regression analysis on the support that individuals with permanent colostomies wanted and health-related QOL resulted in significant associations between “Factors related to daily life” and “Roles in daily life ((β=-.285, p=.014) ,(β=-.363, p=.001).
Conclusions
This study suggested that there were differences in the support that elderly with permanent colostomies wanted depending on the number of months or years passed since their colostomy surgery. Furthermore, it showed that the more they wished for care related to their daily life and health-related QOL.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The author.
Funding
JAPS Grant-in-Aid for Scientific Research(B):25293443.
Disclosure
The author has declared no conflicts of interest.
Resources from the same session
117P - Short-term and long-term outcomes of hepatectomy combined with intraoperative radiofrequency ablation for multiple colorectal liver metastases: A propensity score matching study
Presenter: Wenbai Huang
Session: Poster display session
Resources:
Abstract
119P - The impacts of dose-time-fractionation schedules on pathological complete response rate (pCR) and local recurrence (LR)
Presenter: Fu Jin
Session: Poster display session
Resources:
Abstract
120P - Platelet to lymphocyte ratio is associated with tumour localization and outcomes in patients with metastatic colorectal cancer
Presenter: Ahmet Bilici
Session: Poster display session
Resources:
Abstract
121P - Meta-analysis of three-dimensional versus two-dimensional laparoscopic surgery for rectal cancer
Presenter: Laiyuan Li
Session: Poster display session
Resources:
Abstract
127P - Outcomes based on albumin‐bilirubin (ALBI) grade in the phase III CELESTIAL trial of cabozantinib versus placebo in patients with advanced hepatocellular carcinoma (HCC)
Presenter: Stephen Chan
Session: Poster display session
Resources:
Abstract
128P - Tislelizumab in combination with chemotherapy for Chinese patients (Pts) with gastric/gastroesophageal junction cancer (GC/GEJC) or esophageal squamous cell carcinoma (ESCC)
Presenter: Yuxian Bai
Session: Poster display session
Resources:
Abstract
129P - Monitoring patient-specific mutation in ctDNA and CTC for tumour response evaluation after neoadjuvant chemotherapy in advanced gastric adenocarcinoma (NCT03425058)
Presenter: Tao Fu
Session: Poster display session
Resources:
Abstract
130P - Development of a liver cancer risk prediction model for the general population in china: A potential tool for screening
Presenter: Xiaoshuang Feng
Session: Poster display session
Resources:
Abstract
131P - Cabozantinib in Asian patients with hepatocellular carcinoma and other solid tumours: Population pharmacokinetics analysis
Presenter: Chih-Hung Hsu
Session: Poster display session
Resources:
Abstract
132P - Liposomal irinotecan (nal-IRI) plus 5-fluorouracil/levoleucovorin (5 FU/LV) vs 5-FU/LV in Japanese patients (pts) with gemcitabine-refractory metastatic pancreatic cancer (mPAC)
Presenter: Tatsuya Ioka
Session: Poster display session
Resources:
Abstract